News | CT Angiography (CTA) | September 17, 2019

New ESC Guideline Provides Class 1 Recommendation for Coronary CTA

Continuation of 2013 guidelines recommends coronary CT angiography as initial test to rule out or establish diagnosis of chronic coronary syndromes

New ESC Guideline Provides Class 1 Recommendation for Coronary CTA

September 17, 2019 — The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary syndromes (CCS), which classifies computed tomography angiography (CTA) as a Class 1 recommendation for diagnosing CAD in symptomatic patients. The document, which is a continuation of the 2013 stable coronary artery disease (CAD) guidelines, updates the term to CCS to emphasize the dynamic nature of the disease. It was released at the 2019 ESC Congress, Aug. 31-Sept. 4 in Paris, France, and published simultaneously in the European Heart Journal.1 

Per the guideline, unless obstructive CAD can be excluded based on clinical evaluation alone, either non-invasive functional imaging or anatomical imaging using coronary CTA should be used as the initial test to rule out or establish the diagnosis of CCS.

The new guideline suggests that "Coronary CTA is the preferred test in patients with a lower range of clinical likelihood of CAD, no previous diagnosis of CAD and characteristics associated with a high likelihood of good image quality."

“Depending on patient characteristics, local expertise and availability, as well as patient-specific considerations, physicians should decide between coronary CTA and ischemia testing,” said ESC President-elect Stephan Achenbach, M.D., FSCCT. “This is a recognition of the numerous trials that have been performed to establish the usefulness and reliability of CT angiography as a first-line examination."

“The guideline recommendations are based on data that shows that the use of coronary CTA leads to accurate identification of coronary artery disease, which if treated appropriately, can lead to improved patient outcomes.” added Ron Blankstein, M.D., FSCCT, president of SCCT. “The guidelines recognize that there are multiple factors that should be used in test selection, but that for many, a coronary CTA-first approach is beneficial.”

The guidelines also place stronger emphasis on lifestyle behaviors, and for the first time, address the negative impact of pollution and noise on CCS patients. Additionally, an annual flu vaccination, particularly for elderly patients, is recommended, as is behavioral counseling.

For more information: www.academic.oup.com/eurheartj

 

Reference

1. Knuuti J., Wijns W., Saraste A., et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal, published online Aug. 31, 2019. https://doi.org/10.1093/eurheartj/ehz425


Related Content

Feature | CT Angiography (CTA) | Kyle Hardner

Advances in coronary CT angiography (CCTA) over the past two decades have helped cardiologists detect heart disease in ...

Home February 06, 2026
Home
News | CT Angiography (CTA)

Jan. 9, 2026 — Effective January 1, 2026, Elucid's Plaque-IQ coronary plaque analysis has received a new Category I ...

Home January 09, 2026
Home
News | CT Angiography (CTA)

Dec. 11, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), recently announced two ...

Home December 11, 2025
Home
News | CT Angiography (CTA)

Dec. 8, 2025 — In November, The Lancet published an international expert consensus review, “Contemporary, non-invasive ...

Home December 11, 2025
Home
News | CT Angiography (CTA)

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...

Home October 30, 2025
Home
News | CT Angiography (CTA)

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Home October 29, 2025
Home
News | CT Angiography (CTA)

Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...

Home October 23, 2025
Home
News | CT Angiography (CTA)

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 09, 2025
Home
News | CT Angiography (CTA)

Aug. 11, 2025 — Elucid announced that United Healthcare has updated its cardiac imaging guidelines to align with recent ...

Home August 11, 2025
Home
News | CT Angiography (CTA)

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Home May 02, 2025
Home
Subscribe Now